Ekso Bionics Holdings, Inc. Common Stock (CHRN) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Ekso Bionics Holdings, Inc. Common Stock (CHRN) operates in the Healthcare sector, specifically the Medical - Specialties industry, with a market capitalization near $52.9M, listed on NASDAQ, employing roughly 55 people, carrying a beta of 0.86 to the broader market. Ekso Bionics Holdings, Inc. Led by Scott G. Davis, public since 2026-05-05.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for CHRN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →